IdentificationGeneric Name(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINEDrugBank Accession NumberDB08244BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE (DB08244)× CloseWeightAverage: 354.3931 Monoisotopic: 354.154369682 Chemical FormulaC21H20F2N2OSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUKinesin-like protein KIF11Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentAlpha amino acid amidesAlternative ParentsPhenylpyrrolines / Fluorobenzenes / Aryl fluorides / Tertiary carboxylic acid amides / Pyrroles / Azacyclic compounds / Organopnictogen compounds / Organofluorides / Organic oxides / Monoalkylamines / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituents2-phenylpyrroline / Alpha-amino acid amide / Amine / Aromatic heteromonocyclic compound / Aryl fluoride / Aryl halide / Azacycle / Benzenoid / Carbonyl group / Carboxamide group / Fluorobenzene / Halobenzene / Hydrocarbon derivative / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organofluoride / Organohalogen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Primary aliphatic amine / Primary amine / Pyrrole / Pyrroline / Tertiary carboxylic acid amide


 show 18 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyVCOUEHUEFUDZIS-PMACEKPBSA-NInChIInChI=1S/C21H20F2N2O/c22-16-8-9-18(23)17(11-16)15-10-19(13-4-2-1-3-5-13)25(12-15)21(26)20(24)14-6-7-14/h1-5,8-11,14,19-20H,6-7,12,24H2/t19-,20-/m0/s1IUPAC Name(2S)-2-amino-2-cyclopropyl-1-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrol-1-yl]ethan-1-oneSMILES[H][C@](N)(C1CC1)C(=O)N1CC(=C[C@@]1([H])C1=CC=CC=C1)C1=CC(F)=CC=C1FReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound6102824PubChem Substance99444715ChemSpider4810325BindingDB24060ChEMBLCHEMBL204459ZINCZINC000013982540PDBe LigandN4TPDB Entries2fl2Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00884 mg/mLALOGPSlogP3.04ALOGPSlogP3.43ChemaxonlogS-4.6ALOGPSpKa (Strongest Basic)8.49ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count2ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area46.33 Å2ChemaxonRotatable Bond Count4ChemaxonRefractivity96.75 m3·mol-1ChemaxonPolarizability36.48 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier+0.9789Caco-2 permeable-0.5172P-glycoprotein substrateSubstrate0.5434P-glycoprotein inhibitor INon-inhibitor0.6269P-glycoprotein inhibitor IINon-inhibitor0.8606Renal organic cation transporterNon-inhibitor0.6468CYP450 2C9 substrateNon-substrate0.8622CYP450 2D6 substrateNon-substrate0.7897CYP450 3A4 substrateSubstrate0.5172CYP450 1A2 substrateInhibitor0.6991CYP450 2C9 inhibitorInhibitor0.5935CYP450 2D6 inhibitorNon-inhibitor0.834CYP450 2C19 inhibitorInhibitor0.6677CYP450 3A4 inhibitorInhibitor0.7632CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.927Ames testNon AMES toxic0.6085CarcinogenicityNon-carcinogens0.8798BiodegradationNot ready biodegradable0.9972Rat acute toxicity2.6861 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9923hERG inhibition (predictor II)Inhibitor0.8434  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)2N/AN/AA30281


 Details


 Binding Properties1. Kinesin-like protein KIF11KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionProtein kinase bindingSpecific FunctionMotor protein required for establishing a bipolar spindle. Blocking of KIF11 prevents centrosome migration and arrest cells in mitosis with monoastral microtubule arrays.Gene NameKIF11Uniprot IDP52732Uniprot NameKinesin-like protein KIF11Molecular Weight119158.025 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52 